dasatinib s.k. 50 mg
k.s.kim international (sk- pharma) ltd., israel - dasatinib - film coated tablets - dasatinib 50 mg - dasatinib - dasatinib is indicated for the treatment of adult patients with:• newly diagnosed philadelphia-chromosome-positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase;• chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate;• ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
dasatinib s.k. 70 mg
k.s.kim international (sk- pharma) ltd., israel - dasatinib - film coated tablets - dasatinib 70 mg - dasatinib - dasatinib is indicated for the treatment of adult patients with:• newly diagnosed philadelphia-chromosome-positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase;• chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib mesilate;• ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy.
apo-dasatinib tablet
apotex inc - dasatinib - tablet - 20mg - dasatinib 20mg - antineoplastic agents
apo-dasatinib tablet
apotex inc - dasatinib - tablet - 50mg - dasatinib 50mg - antineoplastic agents
apo-dasatinib tablet
apotex inc - dasatinib - tablet - 100mg - dasatinib 100mg - antineoplastic agents
apo-dasatinib tablet
apotex inc - dasatinib - tablet - 70mg - dasatinib 70mg - antineoplastic agents
apo-dasatinib tablet
apotex inc - dasatinib - tablet - 80mg - dasatinib 80mg - antineoplastic agents
taro-dasatinib tablet
taro pharmaceuticals inc - dasatinib - tablet - 20mg - dasatinib 20mg - antineoplastic agents
taro-dasatinib tablet
taro pharmaceuticals inc - dasatinib - tablet - 50mg - dasatinib 50mg - antineoplastic agents
taro-dasatinib tablet
taro pharmaceuticals inc - dasatinib - tablet - 70mg - dasatinib 70mg - antineoplastic agents